The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was whether the Promise Doctrine should be held as the correct standard of utility under the Patent Act. The SCC’s ruling finds the Promise Doctrine unsound […]

Posted in Access to Medicines, Blogs, Commercialization, Development, Innovation, Patentability, Patents, Pharmaceutical Drugs, Uncategorized
Comment: 1

If we are going to be fair, the cryptocurrency idea dates back to almost forty years ago. In an article published in the Wall Street Journal on August 19, 1977, Friedrich Hayek — the economist and philosopher whose work on a theory of money earned him a Nobel Prize — anticipated that many different types […]

Posted in IP, Open-Source, Patents, Technology, Uncategorized
Comments: 0

This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR genome editing system. Central to the talk was the evolving nature of genome editing technology and the ethical concerns that come with its growing breadth of […]

Posted in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized
Comments: 0

As reported on Kotaku.com – “British Telecommunications, a multinational mega-conglomerate with origins dating back to the 1800s, is suing Valve, a video game company that can’t count to three”. British Telecommunications (BT) alleges that on-line services offered by Valve infringe on four U.S. patents held by BT. The patents at trial are broadly worded and could implicate […]

Posted in Blogs, Cross Border Issues, Gaming, Infringement, Infringement, IP, Patent Trolls, Patentability, Patents, Technology, UK, Uncategorized, US
Comments: 0